Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exparel vs. Bupivacaine Hydrochloride vs. Placebo for Transversus Abdominis Plane Blocks During Open Retromuscular Hernia Repair

NCT03541941 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03541941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03541941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exparel vs. Bupivacaine Hydrochloride vs. Placebo for Transversus Abdominis Plane Blocks During Open Retromuscular Hernia Repair
Lead sponsor
The Cleveland Clinic
Phase
Phase 4
Overall status
Completed
Start date
July 3, 2018
Completion date
December 19, 2019
Enrollment
164 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia, postoperative